Smoking and the risk of type 2 diabetes in Japan: A systematic review and meta-analysis - PubMed
Review
Smoking and the risk of type 2 diabetes in Japan: A systematic review and meta-analysis
Shamima Akter et al. J Epidemiol. 2017 Dec.
Abstract
Cigarette smoking is the leading avoidable cause of disease burden. Observational studies have suggested an association between smoking and risk of type 2 diabetes mellitus (T2DM). We conducted a meta-analysis of prospective observational studies to investigate the association of smoking status, smoking intensity, and smoking cessation with the risk of T2DM in Japan, where the prevalence of smoking has been decreasing but remains high. We systematically searched MEDLINE and the Ichushi database to December 2015 and identified 22 eligible articles, representing 343,573 subjects and 16,383 patients with T2DM. We estimated pooled relative risks (RRs) using a random-effects model and conducted subgroup analyses by participant and study characteristics. Compared with nonsmoking, the pooled RR of T2DM was 1.38 (95% confidence interval [CI], 1.28-1.49) for current smoking (19 studies) and 1.19 (95% CI, 1.09-1.31) for former smoking (15 studies). These associations persisted in all subgroup and sensitivity analyses. We found a linear dose-response relationship between cigarette consumption and T2DM risk; the risk of T2DM increased by 16% for each increment of 10 cigarettes smoked per day. The risk of T2DM remained high among those who quit during the preceding 5 years but decreased steadily with increasing duration of cessation, reaching a risk level comparable to that of never smokers after 10 years of smoking cessation. We estimated that 18.8% of T2DM cases in men and 5.4% of T2DM cases in women were attributable to smoking. The present findings suggest that cigarette smoking is associated with an increased risk of T2DM, so tobacco control programs to reduce smoking could have a substantial effect to decrease the burden of T2DM in Japan.
Keywords: Japanese; Meta-analysis; Smoking; Smoking cessation; Systematic review; Type 2 diabetes.
Copyright © 2017 The Authors. Production and hosting by Elsevier B.V. All rights reserved.
Figures

Flowchart of the selection of studies included in meta-analysis.

Adjusted relative risk for current smokers compared with non-smokers. CI, confidence interval; RR, relative risk.

Adjusted relative risk for past smokers compared with nonsmokers. CI, confidence interval; RR, relative risk.

Linear dose-response relationship between cigarette smokes per day and relative risk of diabetes among total subjects (P for non-linearity = 0.08). Data were modeled with random-effects restricted cubic spline models with three knots placed at 10th, 50th, and 90th percentiles of cigarette smokes per day. Lines with long dashes represent the pointwise 95% confidence intervals for the fitted linear trend (solid line). Line with short dashes represents the linear trend.

Relationship between duration of smoking cessation and relative risk of diabetes. Data were pooled using random-effects meta-analysis from three studies that presented data for duration of smoking cessation. Error bars show 95% confidence intervals.
Similar articles
-
Pan A, Wang Y, Talaei M, Hu FB, Wu T. Pan A, et al. Lancet Diabetes Endocrinol. 2015 Dec;3(12):958-67. doi: 10.1016/S2213-8587(15)00316-2. Epub 2015 Sep 18. Lancet Diabetes Endocrinol. 2015. PMID: 26388413 Free PMC article. Review.
-
Xu H, Suo J, Lian J. Xu H, et al. Int Urol Nephrol. 2018 May;50(5):911-922. doi: 10.1007/s11255-018-1825-x. Epub 2018 Feb 23. Int Urol Nephrol. 2018. PMID: 29476432
-
Akter S, Okazaki H, Kuwahara K, Miyamoto T, Murakami T, Shimizu C, Shimizu M, Tomita K, Nagahama S, Eguchi M, Kochi T, Imai T, Nishihara A, Sasaki N, Nakagawa T, Yamamoto S, Honda T, Uehara A, Yamamoto M, Hori A, Sakamoto N, Nishiura C, Totsuzaki T, Kato N, Fukasawa K, Pham NM, Kurotani K, Nanri A, Kabe I, Mizoue T, Sone T, Dohi S; Japan Epidemiology Collaboration on Occupational Health Study Group. Akter S, et al. PLoS One. 2015 Jul 22;10(7):e0132166. doi: 10.1371/journal.pone.0132166. eCollection 2015. PLoS One. 2015. PMID: 26200457 Free PMC article.
-
Zuo JJ, Tao ZZ, Chen C, Hu ZW, Xu YX, Zheng AY, Guo Y. Zuo JJ, et al. Eur Arch Otorhinolaryngol. 2017 Mar;274(3):1617-1631. doi: 10.1007/s00405-016-4390-x. Epub 2016 Nov 14. Eur Arch Otorhinolaryngol. 2017. PMID: 27844225
-
Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis.
Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Willi C, et al. JAMA. 2007 Dec 12;298(22):2654-64. doi: 10.1001/jama.298.22.2654. JAMA. 2007. PMID: 18073361 Review.
Cited by
-
Ahmad I, Aung MN, Ueno S, Khin ET, Latt TS, Moolphate S, Yuasa M. Ahmad I, et al. Diabetes Metab Syndr Obes. 2021 Apr 20;14:1729-1739. doi: 10.2147/DMSO.S291468. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 33907434 Free PMC article.
-
Smoking as a Target for Prevention of Diabetes.
Yang YS, Sohn TS. Yang YS, et al. Diabetes Metab J. 2020 Jun;44(3):402-404. doi: 10.4093/dmj.2020.0126. Diabetes Metab J. 2020. PMID: 32613778 Free PMC article. No abstract available.
-
Smoking Affects the Post-Stroke Inflammatory Response of Lipid Mediators in a Gender-Related Manner.
Drozd A, Kotlęga D, Dmytrów K, Szczuko M. Drozd A, et al. Biomedicines. 2022 Dec 29;11(1):92. doi: 10.3390/biomedicines11010092. Biomedicines. 2022. PMID: 36672599 Free PMC article.
-
Kuwahara K, Yamamoto S, Honda T, Nakagawa T, Ishikawa H, Hayashi T, Mizoue T. Kuwahara K, et al. J Diabetes Investig. 2022 Apr;13(4):714-724. doi: 10.1111/jdi.13713. Epub 2021 Dec 17. J Diabetes Investig. 2022. PMID: 34786886 Free PMC article.
-
Moradpour F, Rezaei S, Piroozi B, Moradi G, Moradi Y, Piri N, Shokri A. Moradpour F, et al. Sci Rep. 2022 Oct 25;12(1):17892. doi: 10.1038/s41598-022-22779-9. Sci Rep. 2022. PMID: 36284227 Free PMC article.
References
-
- US DHHS . US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; Atlanta, GA: 2014. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General.
-
- Sattar N., Sorensen T., Taylor A.E., Morris R., Munafo M.R. Smoking and diabetes risk: building a causal case with clinical implications. Lancet Diabetes Endocrinol. 2015;3(12):918–920. - PubMed
-
- Bilano V., Gilmour S., Moffiet T. Global trends and projections for tobacco use, 1990-2025: an analysis of smoking indicators from the WHO comprehensive information systems for tobacco control. Lancet. 2015;385(9972):966–976. 14. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical